Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma

Development of drug resistance limits the efficacy of targeted therapies. Alternative approaches using different combinations of therapeutic agents to inhibit several pathways could be a more effective strategy for treating cancer. The effects of the approved epidermal growth factor receptor (EGFR)-...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: Jeannot, Victor, Busser, Benoit, Vanwonterghem, Laetitia, Michallet, Sophie, Ferroudj, Sana, Cokol, Murat, Coll, Jean-Luc, Ozturk, Mehmet, Hurbin, Amandine
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2016
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5108607/
https://ncbi.nlm.nih.gov/pubmed/27877053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S117743
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker